Research
Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f55 (Published 16 January 2013) Cite this as: BMJ 2013;346:f55
Related articles
- Research Methods & Reporting Published: 18 October 2011; BMJ 343 doi:10.1136/bmj.d5928
- Correction Published: 30 January 2013; BMJ 346 doi:10.1136/bmj.f596
- Research Published: 01 October 2013; BMJ 347 doi:10.1136/bmj.f5577
- Editorial Published: 24 January 2013; BMJ 346 doi:10.1136/bmj.f480
See more
- Prevention of venous thromboembolism in patients with cancerBMJ June 01, 2023, 381 e072715; DOI: https://doi.org/10.1136/bmj-2022-072715
- New Yorkers rally against care cutsBMJ May 31, 2023, 381 p1222; DOI: https://doi.org/10.1136/bmj.p1222
- US surgeon general warns about excessive social media use by young peopleBMJ May 26, 2023, 381 p1211; DOI: https://doi.org/10.1136/bmj.p1211
- Diagnosis and management of bipolar disordersBMJ April 12, 2023, 381 e073591; DOI: https://doi.org/10.1136/bmj-2022-073591
- Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and managementBMJ February 27, 2023, 380 e069717; DOI: https://doi.org/10.1136/bmj-2021-069717
Cited by...
- The Evolution of {beta}-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
- Inflammation and Heart Rate-corrected QT Interval: Evidence for a Potentially Reversible Cause of Sudden Death in Patients with Rheumatoid Arthritis?
- Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews
- Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF
- Reducing the Global Burden of Cardiovascular Disease, Part 2: Prevention and Treatment of Cardiovascular Disease
- Reversibility of Cardiac Function Predicts Outcome After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis
- Cardiac Recovery During Long-Term LVAD: Is There an Interaction Between Beta-Blockers and Cardiac Progenitor Cells?
- Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-Analysis
- Beta-blockers in COPD: time for reappraisal
- Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study
- Should COPD stand for "comorbidity-related obstructive pulmonary disease"?
- Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study
- Heart Failure Management in Skilled Nursing Facilities: A Scientific Statement From the American Heart Association and the Heart Failure Society of America
- {beta}-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature
- Reply: Ejection Fraction May Improve But the Scar Still Exists! The Risk May Be Lower But Not Zero
- Beta-Blocker Therapy and Cardiac Events Among Patients With Newly Diagnosed Coronary Heart Disease
- Cardiac Alpha1-Adrenergic Receptors: Novel Aspects of Expression, Signaling Mechanisms, Physiologic Function, and Clinical Importance
- Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study
- {beta}-Blockers Improve Outcomes in Patients with Heart Failure and Low Left Ventricular Ejection Fraction
- {beta} blockers for heart failure: which works best?